On September 13, 2016, the 12th participant was enrolled in our ongoing study of MDMA-assisted therapy for social anxiety in adults on the autism spectrum. A generous donation in support of this study has allowed us to add two additional participants, and we are currently recruiting our 13th and final participant. Sponsored by MAPS, this is a collaborative study between MAPS and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, with blood plasma biomarker analysis conducted by researchers at Stanford University. MAPS-sponsored researcher Alicia Danforth, Ph.D., will present preliminary results from this study on October 8, 2016, at Horizons: Perspectives on Psychedelics in New York City.